Squeezing a dynamometer with your hand takes about 10 seconds. But for longevity researchers, this simple measurement is a cheap, reliable proxy for your muscle mass, neuromuscular signaling, and overall physical resilience. Grip strength has become one of the most studied "functional biomarkers" in cardiology and geriatric literature over the past decade — because it seems to reflect the body's overall integrity, not just how hard you can squeeze.
Much of the discussion around it stops at "reference value tables by age." This article looks at the more striking part: what large-scale studies actually found about its link to mortality.
Published in The Lancet in 2015, the PURE (Prospective Urban Rural Epidemiology) study enrolled 142,861 people across 17 countries; 139,691 with known vital status and grip strength measurements were included in the analysis. Researchers measured grip strength with a Jamar dynamometer and evaluated it alongside 14 other potentially modifiable risk factors, including blood pressure, smoking, and diabetes.
The findings were striking: every 5 kg drop in grip strength was associated with:
The most notable finding: grip strength predicted both all-cause and cardiovascular mortality more strongly than systolic blood pressure did. That doesn't mean blood pressure is unimportant — it remains a critical cardiovascular marker. But it shows that muscle strength, something routinely overlooked in standard checkups, carries a signal that's at least as strong.
To avoid relying on a single study, consider a 2017 meta-analysis published in JAMDA (Journal of the American Medical Directors Association). Wu and colleagues pooled 42 prospective cohort studies covering 3,002,203 participants. Comparing the lowest grip strength group to the highest:
So the link between grip strength and mortality/cardiovascular risk isn't a fluke from one study — it's a pattern replicated across millions of people in different populations. The link to cancer was weaker and inconsistent, so a claim like "low grip strength means high cancer risk" wouldn't be accurate.
Grip strength isn't just a research metric — it's used clinically too. Under the European Working Group on Sarcopenia in Older People's updated criteria (EWGSOP2, 2019), low grip strength is the first screening step for sarcopenia (age-related loss of muscle mass and function). The cutoffs are based on a large normative dataset from Great Britain, representing 2.5 standard deviations below the mean:
People below these thresholds are recommended for further assessment of muscle mass and physical performance. The literature also notes these cutoffs can differ somewhat across populations (for instance, in a German cohort of over 200,000 people) — so the numbers are a reference point, not a universal constant.
This data isn't a diagnostic tool, but it gives a clear direction: maintaining or building grip strength may be as meaningful a longevity target as cardiovascular exercise. Resistance training (2-3 times a week, targeting major muscle groups) is a well-documented way to increase muscle mass and functional strength. If you're curious about your own grip strength, many physical therapy clinics or sports performance centers can measure it cheaply; for people over 40, especially those with sarcopenia risk factors, this measurement can be a useful part of routine health screening.
Grip strength is a cheap, fast, reliable proxy for overall muscle mass and function. It takes 10 seconds to measure, but it correlates with muscle power, neuromuscular signaling, general physical resilience, and, according to some studies, the pace of biological aging.
The 2015 PURE study, published in The Lancet, found in 139,691 people that every 5kg drop in grip strength predicted all-cause and cardiovascular mortality risk more strongly than systolic blood pressure. That doesn't mean blood pressure doesn't matter — when both were evaluated together, grip strength simply came out as the stronger predictor.
Under the EWGSOP2 (European Working Group on Sarcopenia in Older People, 2019) criteria, grip strength below 27 kg in men and below 16 kg in women is considered low, and is used as the first screening step for sarcopenia.
These studies are observational — they show an association between grip strength and risk, but there's no large-scale intervention trial proving that building grip strength through resistance training lowers mortality risk. That said, resistance training's benefits for muscle mass, balance, and general health are well supported by other evidence.
"A number you can measure in 10 seconds with a dynamometer may say more than most lab tests. But it isn't fate — it's changeable."
— Vivelong Longevity Science Team